Development of indicators for patient-centred cancer care by Ouwens, Mariëlle et al.
ORIGINAL ARTICLE
Development of indicators for patient-centred cancer care
Mariëlle Ouwens & Rosella Hermens & Marlies Hulscher & Saskia Vonk-Okhuijsen &
Vivianne Tjan-Heijnen & René Termeer & Henri Marres & Hub Wollersheim &
Richard Grol
Received: 15 September 2008 /Accepted: 2 April 2009 /Published online: 23 April 2009
# The Author(s) 2009. This article is published with open access at Springerlink.com
Abstract
Purpose Assessment of current practice with a valid set of
indicators is the key to successfully improving the quality of
patient-centred care. For improvement purposes, we developed
indicators of patient-centred cancer care and tested them on a
populationofpatientswithnon-smallcelllungcancer(NSCLC).
Methods Recommendations for patient-centred care were
extracted from clinical guidelines, and patients were
interviewed to develop indicators for assessing the patient-
centredness of cancer care. These indicators were tested
with regard to psychometric characteristics (room for
improvement, applicability, discriminating capacity and
reliability) on 132 patients with NSCLC treated in six
hospitals in the east Netherlands. Data were collected from
patients by means of questionnaires.
Results Eight domains of patient-centred cancer care were
e x t r a c t e df r o m6 1o n c o l o g yg u i d e l i n e sa n d3 7p a t i e n t
interviews and were translated into 56 indicators. The
practice test amongst patients with NSCLC showed the most
room for improvement within the domains ‘emotional and
psychosocial support’, ‘physical support’ and ‘information
supply’. Overall, 26 of the 56 indicators had good psycho-
metric characteristics.
Conclusions Developing a valid set of patient-centred
indicators is a first step towards improving the patient
centredness of cancer care. Indicators can be based on
recommendations from guidelines, but adding patient opin-
ions leads to a more complete picture of patient centredness.
The practice test on patients with NSCLC showed that the
patient centredness of cancer care can be improved. Our set
of indicators may also be useful for future quality assess-
ments for other patients with cancers or chronic diseases.
Keywords Cancer.Oncology.Qualityindicators.
Healthcare.Patient-centredcare.Qualityofhealthcare
Introduction
As a cause of death in the USA and Europe, cancer is ex-
ceeded only by cardiovascular disease [2]. Earlier diagnosis,
improved treatment modalities and enhanced supportive care
result in cancer taking on the characteristics of a chronic
disease more and more [32]. The management of care for
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e-mail: M.Ouwens@iq.umcn.nlcancer patients is complex. First, cancer has a very significant
impact on the patient’s physical, emotional and social well-
being. Second, various professionals are involved in preven-
tion, diagnosis, treatment and follow-up. This complexity can
lead to suboptimal care and result in discontinuity and
fragmentation of care [1, 20, 24]. Therefore, there is a need
to organise health care delivery in a way that is more patient
centred and not disease or provider centred. Patient centred-
ness means that care is organised around the physical, social
and emotional needs and preferences of patients and that
patients are actively involved in their own care [25, 36].
Literature shows that the patient centredness of cancer
care can be improved in several ways, such as more
supportive care, better communication, better information
supply and better cooperation amongst physicians [23, 30,
35]. To improve the quality of the patient centredness of care
for patients with cancer, current practice needs to be reliably
assessed [15]. However, this assessment is not straightfor-
ward, and selecting appropriate indicators to assess care is
difficult. Evidence-based clinical guidelines for the manage-
ment of patients with cancer can provide recommendations
for patient-centred care. The available recommendations
from these guidelines should be combined with opinions of
the patients themselves so that we can assess additional
aspects for which evidence alone is insufficient or absent
[18]. To measure the quality of patient centredness, ‘patient-
centred’ recommendations in these guidelines need to be
translated into so-called quality indicators. Quality indicators
are ‘measurable elements of practice performance for which
there is evidence or consensus that they can be used to assess
the quality of care’ [8]. There are some well-known instru-
ments for measuring patient satisfaction [3, 4] and patients’
experiences [21, 22]. These instruments are based on existing
patient-satisfaction questionnaires, interviews and focus
groups. However, quality indicators for measuring patient
centredness of cancer care based on evidence-based guide-
lines and opinions of patients do not exist.
This study reports the first step in improving patient-
centred cancer care in which we have systematically
developed a set of indicators to measure the patient centred-
ness of cancer care. We used a practice test to assess both the
feasibility of this set of indicators with regard to psychomet-
ric characteristics and the quality of patient-centred cancer
care for patients with non-small cell lung cancer (NSCLC) in
the Dutch eastern comprehensive cancer region.
Materials and methods
Development of indicators
The development of indicators started with a search for
evidence-based guidelines regarding the management of
patients with all types of cancer. We searched the two
largest English-language national databases for evidence-
based guidelines (UK: National Institute for Health and
Clinical Excellence; USA: Agency for Healthcare Research
and Quality) and the Dutch oncology database Oncoline
(www.oncoline.nl; www.guideline.gov; www.nice.org.uk).
All guidelines for the general management of patients with
all types of cancer were included. Guidelines for specific
aspects of care management for patients with cancer were
excluded (e.g. pain management). One researcher extracted
all the recommendations from the guidelines that had to do
with organising care around the physical, social and
emotional needs and the preferences of patients. We used
a semi-structured method to interview 30 patients with head
and neck cancer, as well as all seven patient representatives
from the Dutch national association of patients with lung
cancer. The interviewer read the recommendations aloud,
and the patients and their representatives were asked to
rate the recommendations on a nine-point Likert scale to
determine their degree of importance for the patient centred-
ness of care (a score of 1 meant ‘not important at all’ and 9
meant ‘very important’). They were also given a chance to
add new items. All recommendations with a mean score of
8 points or more were included in the final set. Domains
were extracted from the guidelines and two researchers
classified all the recommendations into the domains of
patient centredness. Two researchers translated the recom-
mendations into indicators, a process of defining numerators
and denominators. A panel of four researchers judged the
translation process from recommendation to indicator
(Fig. 1).
Questionnaire
The indicators were reflected in a questionnaire for cancer
patients. The questionnaire asked patients for their actual
experiences with care and not for their satisfaction. We
asked patients with NSCLC to rate their experiences
regarding 56 aspects of patient-centred care on a four-point
Likert scale (1 = not done; 2 = done, but inadequately; 3 =
done adequately; 4 = done excellently) or on a YES or NO
scale. The indicators evaluated on a Likert scale were coded
as dichotomous scores: adherence to the indicator ‘yes’
(score 1 or 2) or ‘no’ (score 3 or 4). These 56 aspects of care
are part of one of the eight domains of patient-centred care,
namely, access (e.g. ‘Did you start therapy within 35 days of
your first visit to the specialist’), follow-up (‘Did you know
which medicine to take at home?’), communication and
respect (‘Do you trust your specialist?’), involvement (‘Were
family and friends involved during care and follow-up?’),
information (‘Did you receive written information about
treatment?’), coordination (‘Did you know how to reach
specialists?’), physical support (‘Did you get support to
122 Support Care Cancer (2010) 18:121–130control your pain?’) and emotional and psychosocial support
(‘Did the specialist ask about fear and your mental state?’).
Practice test
The questionnaire was tested in a group of 132 patients
with NSCLC. This practice test took place in six hospitals
in the Dutch eastern comprehensive cancer region (Table 1).
The period patients were asked to evaluate was from the
first visit until the beginning of treatment. After the ethics
committee of the Radboud University Medical Centre in
Nijmegen, The Netherlands approved the study, we included
all consecutive patients newly diagnosed with NSCLC in the
6 months from September 2004 to February 2005 inclusive.
The staff members of the Eastern Comprehensive Cancer
Centre retrospectively included the patients by pathology
diagnosis. Eachhospital’s pulmonologist checked the patient
records to ensure that all questionnaire recipients were still
alive. The researchers sent the questionnaires to the patients’
homes, in a way that ensured patient anonymity, after the
inclusion period had ended. The questionnaires were
accompanied by a letter from each patient’s own pulmonol-
ogist. A reminder was sent to each patient who had not
replied after 2 weeks.
To test the feasibility of our set of indicators, we
assessed the following psychometric characteristics: room
for quality improvement, applicability, and discriminating
capacity and reliability. Indicators must be capable of
detecting improvements in the quality of care. If, for
example, indicator performance is invariably high, there is
little room for improvement. We considered that room for
improvement was limited when the score for an indicator
was 90% or more [31]. Applicability was measured as the
proportion of patients to whom the indicator was applica-
ble. Applicability was considered poor if this proportion
was less than 75% [31, 34]. When the range between the
lowest and highest hospital scores is broad (we assumed
20% or more), an indicator has discriminating potential and
is sensitive in detecting differences.
Ultimately, we tested all the indicators that fulfilled the
psychometric criteria for reliability regarding the eight
domains of patient centredness by calculating Cronbach’s
alpha coefficients for the domains. A Cronbach’s alpha
score of 0.7 or more implies that the measures within one
domain are reliably related to other measures included
within the same domain [12].
Results
Development of indicators
We found 61 evidence-based oncology guidelines in the three
databases, from which we extracted 56 recommendations.
Number Percentage (range)
Teaching hospital 4 67
Hospital beds, mean (range) 630 (200–960)
Lung cancer patients (NSCLC) seen per year, mean (range) 100 (30–160)
Availability of a multidisciplinary team for lung cancer 2 33
Specialised nurse with coordination tasks 1 17
Table 1 Descriptive character-
istics of the six hospitals
Search for evidence-based cancer 
guidelines: NICE, AHRQ, Oncoline 
n = 61
Extraction of patient-centred 
recommendations  
n = 56  
Classification of the recommendations into 
patient-centred domains 
n = 8 
Semi structured interviews with patients for 
patient opinions and additions 
Translation of the recommendations into 56 
indicators reflected in a questionnaire 
Practice test of the 56 indicators on: 
improvement potential, applicability, and 
discriminating capacity 
26 Indicators met all required psychometric 
characteristics based on 26 
recommendations 
Fig. 1 Study design
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found all the recommendations important (mean score of 8 or
more), so we included all of them [10]. Adding patient
opinions had added value concerning criteria for waiting
times and information supply. The guidelines often recom-
mended speeding up the diagnosis and starting treatment as
soon as possible. However, they provided hardly any
concrete information about acceptable waiting times. The
criteria for waiting and throughput times in our study came
from the patient interviews as answers to the question of
acceptable waiting times. Furthermore, the patients added
three specific information items, namely, ‘information about
the possible course of the disease’, ‘the possibility of a second
opinion’ and ‘information about the treatment option of “no
active therapy”’. The eight domains of patient centredness are
access, follow-up, communication and respect, patient and
family involvement, information, coordination, physical
support and emotional and psychosocial support. The
domains most often mentioned in the guidelines were
‘follow-up’ (38%), ‘emotional and psychosocial support’
(34%) and ‘multidisciplinary patient care team’ (30%). The
least mentioned domain was ‘paramedical support, e.g.
dietician’ (10%; Table 3). All the recommendations were
translated into a set of 56 indicators (Fig. 1).
Practice test
Study population
During the study period of 6 months, a population of 276
patients with NSCLC were included. However, because
many patients with NSCLC die within months after
diagnosis, we were only able to send 132 of the 276 patients
a questionnaire.
All patients received the questionnaire 2 to 6 months after
their first visit to the pulmonologist. Seventy-six percent of
the patients returned the questionnaire. The responders (n=
100) and non-responders (n=32) did not significantly differ
in sex, age and disease stage (Table 2).
Psychometric characteristics: room for improvement
The least room for improvement was found within the
domains ‘communication and respect’ (mean score of 95%
and all indicators in this domain scored 89% or more),
followed by the domain ‘patient and family involvement’
(mean score of 84% and individual scores of 71% or more;
Table 4) Most room for improvement was found within the
domains ‘physical support’, ‘emotional and psychosocial
support’ and ‘information’. Patients did get physical
support during the hospital stay (80%), but hardly any at
home (36%), and only 58% of the patients felt that they had
received enough support to control their physical com-
plaints of pain, suffocation, nausea, weight loss, insomnia,
tingling and blood coughs (Table 4). About one third of the
patients stated that they were asked if they had psycholog-
ical complaints or had problems with living conditions, but
only 39% of the patients who needed support from
caregivers who specialise in mental health actually got this
care (Table 4). Regarding information, only 19% of the
patients stated that they received enough information about
all ten information items (Table 4). The information items
mentioned most often were ‘aim and follow-up of diagnos-
tic procedures’ and ‘treatment options and pros and cons’.
The items mentioned least were ‘availability of emotional
support’, ‘opportunity of contacting a companion in
distress’ and ‘the possibility of a second opinion’. Overall,
44 of the 56 indicators (79%) had an improvement potential
of 10% or more (Fig. 2).
Psychometric characteristics: applicability
We found that ten of the 56 indicators were applicable to
less than 75% of the population (Table 4). Low applicabil-
ity scores were found for some indicators regarding
oncology nurses, patients in need of specialised mental
care who actually received this support, involvement of
paramedical professionals and involvement of home care.
Overall, 46 indicators had good applicability (Fig. 2).
Psychometric characteristics: discriminating capacity
Our study showed that 36 indicators had scores with a
range of 20% or more between the highest and lowest
scoring hospitals (Table 4). The largest ranges between the
six hospitals were for the indicators ‘patients receive
support from caregivers who specialise in mental health if
needed’ (the lowest hospital score was 0% and the highest
Response (n=100) [n (%)] Non-response (n=32) [n (%)]
Mean age in years 66 68
Men 65 (66) 19 (60)
Disease stage IV 23 (24) 9 (32)
Other cancer 5 years or longer ago 9 (9) 6 (18)
Table 2 Descriptive character-
istics of the 132 patients
124 Support Care Cancer (2010) 18:121–130was 100%) and ‘specialist asked patient about fear and
mental state’ (the lowest hospital score was 32% and the
highest was 100%).
Psychometric characteristics: reliability
The best indicators for quality improvement are those that
have more that 10% room for improvement, good applica-
bility (75% or more) and good discriminating capacities (at
least 20% difference between lowest and highest scoring
hospitals). In our study, 26 of the 56 indicators had good
scores on all three psychometric characteristics (Fig. 2).
They cover eight domains of patient centredness as shown
in grey in Table 3. The recommendations on which these
indicators are based are shown in Table 4. Seven of these
eight domains had a Cronbach’s alpha of 0.67 or more, and
the reliability was acceptable. The domain ‘coordination of
specialists’ had an alpha of 0.22 (Table 5).
Discussion
Patient centredness is an important principle for delivering
high-quality integrated care. Before patient centredness can
be improved, it must be assessed with a valid set of
indicators. The development of a valid set of indicators for
patient centredness that is applicable to all patients with
cancer is an initial step towards improving the care. In our
study, we developed 56 indicators for patient centredness
covering eight domains of cancer care. There was consid-
erable variation in the domains discussed in the guidelines.
The indicators were evaluated in a practice test of the
following psychometric characteristics: room for improve-
ment, applicability and discriminating capacity and reliability.
Twenty-six of the 56 indicators for patient-centred cancercare
had good psychometric characteristics and were tested for
reliability.
The eight domains of patient-centred cancer care cor-
respond to patient-centred care dimensions that others
mention (www.pickerinstitute.com)[ 28]. We recommend
that specific domains for patient centredness always be
addressed in clinical guidelines for the management of
patients with cancer, such as, for example, the domains
mentioned in this study. Although the literature shows that
oncology guidelines have significantly higher scores for the
consideration of patients’ views than guidelines for other
patient groups [6], we found a large variation within
oncology literature covering patient-centred issues. The
relatively few patient-centred recommendations in some
guidelines may be due to the fact that patients are often not
involved in guideline development. However, this is one of
the key criteria for good clinical guidelines as proposed by
the Appraisal of Guidelines Research and Evaluation
collaboration [14]. We believe that involving patients in
both guideline development and indicator development
may improve patient centredness. In our study, involving
patients in indicator development resulted in some addi-
tional points that would not otherwise have been noticed as
information items and criteria for waiting and throughput
times.
The literature provides only a few studies about indicator
development [26, 27], and our study is the first to develop
and test a general set of indicators for patient-centred cancer
care. Our method of combining recommendations from
Table 3 Patient-centred domains in 61 general oncology guidelines
Oncoline (n=14) AHRQ (n=36) NICE (n=11) Total (n=61)
n % n % n % n %
1. Access to care 1 7 2 6 5 45 8 13
2. Follow-up 12 86 13 36 6 55 23 38
3. Communication and respect 2 14 6 17 2 18 10 16
4. Patient and family involvement 2 14 4 11 2 18 8 13
5. Information 4 29 5 14 6 55 15 25
6. Coordination
Specialists/multidisciplinary patient care team 4 29 5 14 9 82 18 30
Oncology nurse with case management tasks 2 14 5 14 6 55 13 21
Paramedical support 3 21 3 27 6 10
7. Physical support (pain, nausea, etc.) 3 21 4 11 5 50 12 20
8. Emotional and psychosocial support 9 64 6 17 6 55 21 34
The table shows the number of times a patient-centred domain was mentioned in the guideline, e.g. recommendations on follow-up were
mentioned in 38% of all guidelines (23 of 38)
AHRQ Agency for Healthcare Research and Quality, NICE National Institute for Health and Clinical Excellence
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Domains of patient-centred cancer care (total n=100) Score
(%)
Room for improvement
(%)
Applicability
(%)
Range
(%)
1. Access (mean score, 68%)
Waiting time first visit lung specialist <5 days 49 51 100 42–56
Waiting time start first treatment from first visit specialist <35 days
a 62 38 100 40–80
Waiting time diagnostic procedures from first visit specialist <21 days
a 71 29 100 50–89
Waiting time general practitioner <2 days 90 10 100 82–100
2. Follow-up (mean score, 81%)
Home care knows about the patient’s situation 46 54 64 14–80
Patient knows which activities are allowed at home
a 70 30 91 57–86
Patient knows which side effects to be aware of
a 73 27 86 55–100
Patient knows when to contact the primary care doctor or specialist
a 77 23 98 57–100
Patient knows at discharge which medication to take and why 89 11 94 83–100
The primary care doctor knows about the patient’s situation 92 8 93 83–100
Patient follow-up takes place on an agreed schedule 95 5 98 87–100
Specialist has enough time during consultations 95 5 100 93–100
Patient can reach the specialist between consultations 94 6 83 89–100
3. Communication and respect (mean score, 95%)
Specialist showed interest in you as a person
a 89 11 99 67–100
Specialists talked to others as if you were not there 95 5 95 91–100
Nurses talked as if you were not there 96 4 93 91–100
Nurses showed interest in you as a person 96 4 97 86–100
Patient trusts in the specialists 97 3 98 91–100
Patient trusts the nurses 97 3 96 86–100
Patient feels respected during treatment 98 2 99 91–100
4. Patient and family involvement (mean score, 84%)
Nurses involved family and friends during care and follow-up
a 71 29 98 61–100
Specialists involved family and friends during treatment and follow-up
a 82 18 97 73–100
Specialists shared the decision making with the patient
a 82 18 97 67–100
Family and friends had opportunities to ask the specialists questions
a 83 17 94 60–100
Family and friends had opportunities to ask the nurses questions
a 86 14 89 76–100
Patient had the knowledge and support to make decisions 88 12 97 82–100
Patient had opportunities to ask questions
a 89 11 98 76–100
Specialists discussed aim and follow-up of the treatment with the patient 92 8 99 87–100
5. Information (mean score, 68%)
Patient received information on all ten information items
a (see note
under Table 5)
19 81 95 17–57
Patient received written information
a 75 25 99 64–86
Patient received clear answers from the nurses 77 13 97 83–100
Patient received contradictory information 79 11 94 85–100
Patient received clear answers from the specialists
a 90 10 100 77–100
6. Coordination (mean score, 71%)
Coordination: specialists (mean score, 87%)
Specialists involved knew patient’s history 83 17 94 75–94
Patient knew how to reach specialists
a 84 16 100 65–100
Patient knew about being discussed in a multidisciplinary team of
specialists
a
85 15 100 67–100
Specialists involved took care of the coordination
a 87 13 75 73–100
Patient knew which specialist is his main contact person 95 5 100 87–100
Coordination: specialised nurse(s) (mean score, 55%)
Oncology nurse was present during bad news consultation
a 36 64 100 21–63
126 Support Care Cancer (2010) 18:121–130guidelines with patients’ opinions led to a large set of
indicators. The usefulness of a quality indicator depends on
various psychometric characteristics, and we decided to test
our set of indicators on some psychometric characteristics
to come up with a core set. There are not many studies on
psychometric characteristics of indicators or norms for
’good characteristics’. Our choice of psychometric criteria
and norms was based on the literature and our experiences
in other studies and was therefore disputable. We chose
‘room for improvement’ because indicators that invariably
have high scores provide little room for improvement and
are therefore less suited for quality improvement. Other
criteria for good indicators are ‘applicable to a large part of
the population’ and ‘high variation between hospitals’.W e
did not test the indicator set for criterion validity because a
golden standard for patient centredness is lacking.
Further research should test the original set of 56
indicators on other populations of cancer patients to provide
additional evidence for the applicability of these indicators.
The scores for the criterion ‘room for improvement’
shows many improvement opportunities for patients with
NSCLC.Inlinewithotherstudies, ourpracticetestregarding
patients with NSCLC showed that patients reported poor
management and evaluation of their physical symptoms and
psychosocial problems, and they were not fully informed
[23, 30, 35]. Cancer is a serious and life-threatening illness,
especially for patients with NSCLC, because the disease
is most often incurable [19]. The impact of lung cancer
and its symptoms on the patient’s psychological, social
Table 4 (continued)
Domains of patient-centred cancer care (total n=100) Score
(%)
Room for improvement
(%)
Applicability
(%)
Range
(%)
Existence of an oncology nurse was known by patient
a 53 47 93 33–86
Patient knew how to reach oncology nurse
a 53 47 100 46–86
Oncology nurse knew patient’s history 61 39 29 38–100
Oncology nurses took care of the coordination 71 29 50 50–100
Coordination: Paramedics (mean score, 70%)
Patient knew how to reach paramedic professionals 55 45 61 36–100
Paramedic professionals involved knew patient’s history 76 24 62 53–100
Paramedic professionals involved took care of the coordination 80 20 43 50–100
7. Physical support (mean score, 58%)
Patient got support for daily activities at home 36 74 72 10–40
Patient got support to control physical complaints
a 58 42 89 25–78
Patient got support for daily activities in the hospital 80 20 88 73–92
8. Emotional and psychosocial support (mean score, 46%)
Patient was offered contact with companion in distress
a 13 87 100 0–43
Patient was asked whether he had psychological complaints
a 34 66 83 18–60
Patient was asked whether he had problems with living conditions
a 36 64 85 23–60
Patient received support from specialised caregivers in mental health if
needed
39 61 28 0–100
Specialist asked patient about fear and mental state
a 52 48 88 32–100
Patient received emotional support from nurses if needed 74 26 65 63–100
Patient received emotional support from specialists if needed 74 26 60 46–100
aIndicator that met all psychometric characteristics
Fig. 2 The 56 indicators and their psychometric characteristics
Support Care Cancer (2010) 18:121–130 127and physical state should be identified early, and patients
should be referred to the appropriate specialist for further
assessment, if needed. The literature shows that screening
lists for quality-of-life issues could be helpful [11]a n dt h a t
structured follow-up by nurses can improve psychosocial
functioning [29]. Failure to provide sufficient information
about disease-related issues is the most frequent source of
patient dissatisfaction [13]. A good supply of information
has positive effects on patient satisfaction and quality of
life [16]. Suggested interventions in the literature to make
sure that patients are informed properly include printed
material [9], consultation preparation packages [7]a n d
audiocassettes of consultations[5].
There are some good examples of instruments that
measure patient satisfaction and patient experiences [3, 4,
21, 22], but they are not based on clinical guidelines. Our
focus on the evaluation of clinical guidelines can be seen as
a complement to other measures to obtain patients’ assess-
ments of the quality of health care. Our evaluation shows
an original and innovative approach to the practice test and
Table 5 Recommendations for patient-centred cancer care tested on patient with non-small cell lung cancer
Alpha
coefficient
Access
Patient receives all necessary diagnostic procedures within 21 days after his first visit to the specialist 0.87
Patient starts his treatment within 35 days after his first visit to the specialist
Follow-up
Patient knows which side effects to be aware of at home 0.78
Patient knows which activities are allowed at home
Patient knows when to contact the primary care doctor or specialist
Communication and respect
Specialist shows interest in the patient as a person
Patient and family involvement
Nurses involve family and friends during care and follow-up 0.85
Specialists involve family and friends during treatment and follow-up
Specialists share the decision making with the patient
Family and friends have opportunities to ask the specialists questions
Family and friends have opportunities to ask the nurses questions
Patient has opportunities to ask questions
Information
Patient receives information on all ten items if applicable
a 0.78
Patient receives written information on all applicable items
a
Patient receives clear answers from the specialists
Coordination: specialists
Patient knows how to reach the specialists 0.22
Patient knows being discussed in a multidisciplinary team of specialists
The specialists involved take care of the coordination
Coordination: oncology nurse(s)
An oncology nurse was present during the bad news consultation 0.68
Patient knows that nurses specialising in oncology exist
Patient knows how to reach the oncology nurse
Physical support
Patient gets support to control physical complaints such as pain, suffocation, nausea, blood coughs, tingling, weight loss and
insomnia
Emotional support
Patient is offered contact with a companion in distress 0.67
Patient is asked about psychological complaints
Patient is asked whether has problems with living conditions
Specialist asks the patient about possible fear and mental state
aAim and follow-up of diagnostic procedures, treatment options and pros and cons, treatment option ‘no active therapy’, estimation of possible
course of illness, possible loss of weight during treatment and the importance of eating well, options for pain medication, options for anaesthesia
in case of operation, opportunities for emotional support, companion in distress, possibility of a second opinion
128 Support Care Cancer (2010) 18:121–130development of indicators for patient centredness in cancer
care. Our set of indicators can be useful to anyone interested
in measuring the degree of patient centredness of cancer
care. The recommendations on which the indicators are
based are not part of all general oncology guidelines. The
recommendations for patient centredness on which the
indicators are based could be considered for incorporation
into general oncology guidelines.
The indicators of patient centredness were measured by
means of patient questionnaires. Obviously, the subjective
opinion of patients may have biased the outcome to some
degree. The outcome of treatment and the stage of the
disease may have had a negative impact on the recall of
initial conversations with the doctor. To deal with this, we
asked patients for their actual experiences of clinical care,
as suggested in the literature, and not for their satisfaction
with care provided [10]. It should be noted that the literature
is contradictory about the influence of patient character-
istics on their assessments of care [17, 33].
Conclusion
In conclusion, the development of a valid set of indicators
for the patient centredness of cancer care is an initial step
towards improvement. Indicators can be based on recom-
mendations from guidelines, but adding patients’ opinions
leads to a more complete picture of patient centredness. In
this study, we have developed and tested a general set of
indicators for patient centredness. Our practice test showed
that many of them appeared to be useful for patients with
NSCLC and that there are many improvement opportunities.
Our set of indicators may also be useful for future quality
assessments for other patients with cancers or chronic
diseases. Therefore, the indicators developed in this study
should be verified in a practice test in other patient groups
to see which indicators also apply to them.
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